WGS - GeneDx Year-over-year earnings per share growth for the last twelve months

Corporate emblem and logo of GeneDx Holdings Corp. (WGS)

GeneDx Holdings Corp. (WGS) is scaling its business through Big Data, monetizing its rare mutation database for pharma behemoths. Relative quarterly EPS dynamics visualize the company's adaptability, where the -55.50 metric reflects current trends. Revenues are based on high-precision exome sequencing for the diagnosis of hereditary pathologies. The business is currently reaching operational profitability, leveraging the pediatric genomic market, which remains independent of macroeconomic factors.

genedx.com (WGS) Year-over-year earnings per share growth for the last twelve months: for the period 04/28/2023 - 11/17/2026

Summary analytical data breakdowns for genedx.com (WGS)

- share price and expert price forecast:
- market capitalization statistics:
Summary company analysis:GeneDx Holdings - WGS
Flagship merchandise of GeneDx Holdings Corp.

For GeneDx Holdings Corp. (WGS), the implementation of whole-genome sequencing in pediatrics directly impacts the rate of profit capitalization. This metric measures the percentage change in net income per share between quarters, reflecting real-time cost management efficiency. By analyzing the quarterly EPS trend profile, an investor can see the conversion of operational scale into shareholder value. Growth in this indicator confirms the successful monetization of genetic data, serving as the primary signal of the company's transition toward sustainable profitability.

Competitors of GeneDx Holdings Corp.

TEM: Quarterly EPS earnings growth|Qiagen Corp - Year-over-year earnings per one share growth for the last 12 months|IONS (Ionis Pharmaceuticals) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months RGEN (Repligen)|Quarterly EPS earnings growth RNA|CRSP (CRISPR Therapeutics) - Year-over-year earnings per one share growth for the last 12 months|Ultragenyx Pharmaceutical - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Beam Tx BEAM|Sarepta Therapeutics - Quarterly EPS earnings growth|Twist Bioscience (TWST) - Year-over-year net earnings per share growth for the last 12 months|TXG: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Intellia Therapeutics Inc (NTLA)|STOK (stoketherapeutics.com) - Quarterly EPS earnings growth|BLFS (BioLife Corp) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months Wave Life Sciences Ltd. (WVE)|Year-over-year earnings per share growth rate for the last twelve months MAZE|sionnatx.com - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months PRME|TSHA - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months uniQure Corp|meiragtx.com (MGTX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months RGNX|Year-over-year net earnings per share growth for the last 12 months SLDB|Quarterly EPS earnings growth Ocugen Inc|Year-over-year earnings per share growth for the last twelve months PacBio Corp (PACB)|Year-over-year net earnings per share change for the last twelve months Benitec Corp|Quarterly EPS earnings growth DSGN (Design Therapeutics, Inc.)|Quarterly EPS earnings growth rocketpharma.com RCKT|4DMT - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Lexeo Therapeutics, Inc.|Korro Bio (KRRO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months EDIT|SLN (Silence Therapeutics plc) - Quarterly EPS earnings growth|proqr.com (PRQR) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months CDXS (Codexis Bio)|SGMO - Earnings per share growth in annualized terms for the last twelve months|Nautilus Biotechnology, Inc. - Year-over-year net earnings per share growth for the last 12 months|Net earnings per share growth for the trailing year Metagenomi, Inc|Precision BioSciences - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year generationbio.com (GBIO)|Boundless Bio Inc (BOLD) - Year-over-year earnings per share growth for the last twelve months|Exicure Inc. - Year-over-year earnings per one share growth for the last 12 months|IMNN (imunon.com) - Quarterly EPS earnings growth|Phio Pharmaceuticals - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Mustang Bio Corp (MBIO)|Quarterly EPS earnings growth TransCode (RNAZ)|Quarterly EPS earnings growth BNGO (bionanogenomics.com)|APDN (Applied DNA Sciences Inc) - Year-over-year net earnings per share trend for the last twelve months|BLUE - Year-over-year earnings per share growth for the last twelve months|ImmunoPrecise Antibodies Ltd. (IPA) - Year-over-year net earnings per share growth for the last 12 months|OMGA (Omega) - Year-over-year net earnings per share growth for the last 12 months|singulargenomics.com (OMIC) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months RGLS|Syros (SYRS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months telesisbio.com (TBIO)|TCON - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth UBX (Unity Biotechnology Inc.)